Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news


MSD drops diabetes lawsuit

Posted 14 October 2020

MSD has dropped a Federal Court lawsuit launched against Indian generics giant Lupin for allegedly threatening to infringe its patent on multi-million dollar diabetes drugs Januvia and Janumet.

The US pharmaceutical company filed a notice of discontinuation on October 8 - less than six weeks after commencing proceedings and the case was delared discontinued last week.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Top of the Hill
How much to save the kid?
We paid a high price for our elderly so what about children
Special Report
Aust Covid Vaccine Tracker
UPDATES: Sanofi/GSK sign Statement of Intent with Gavi; Aust to import 3.8m vax doses
Approvals Action
Novartis' triplet inhaler ticked
First-in-class maintenance treatment of asthma